A detailed history of Riverview Trust CO transactions in Viatris Inc stock. As of the latest transaction made, Riverview Trust CO holds 4,245 shares of VTRS stock, worth $52,638. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,245
Previous 1,852 129.21%
Holding current value
$52,638
Previous $19,000 157.89%
% of portfolio
0.04%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$10.32 - $12.13 $24,695 - $29,027
2,393 Added 129.21%
4,245 $49,000
Q1 2024

Apr 12, 2024

BUY
$11.27 - $13.53 $20,872 - $25,057
1,852 New
1,852 $22,000
Q3 2022

Oct 27, 2022

SELL
$8.48 - $11.13 $9,845 - $12,921
-1,161 Reduced 38.53%
1,852 $16,000
Q1 2022

Apr 21, 2022

BUY
$9.81 - $15.4 $11,389 - $17,879
1,161 Added 62.69%
3,013 $33,000
Q1 2021

Apr 19, 2021

BUY
$13.59 - $18.54 $25,168 - $34,336
1,852 New
1,852 $26,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Riverview Trust CO Portfolio

Follow Riverview Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverview Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Riverview Trust CO with notifications on news.